Law360 (February 22, 2018, 7:26 PM EST) — The Patent Trial and Appeal Board on Wednesday upheld the validity of a patent covering Biogen Inc. and … 7,820,161 B1 was doomed by Celltrion and Pfizer’s inability to prove one of the main pieces of prior art they relied on was public before the patent …
